| Epidemic profile of Shiga-toxin–producing Escherichia coli O104: H4 outbreak in Germany C Frank, D Werber, JP Cramer, M Askar, M Faber, M an der Heiden, ... New England Journal of Medicine 365 (19), 1771-1780, 2011 | 1465 | 2011 |
| Large and ongoing outbreak of haemolytic uraemic syndrome, Germany, May 2011 C Frank, MS Faber, M Askar, H Bernard, A Fruth, A Gilsdorf, M Höhle, ... Eurosurveillance 16 (21), 19878, 2011 | 230 | 2011 |
| Herpes zoster in Germany: quantifying the burden of disease B Ultsch, A Siedler, T Rieck, T Reinhold, G Krause, O Wichmann BMC infectious diseases 11, 1-8, 2011 | 148 | 2011 |
| Methods for health economic evaluation of vaccines and immunization decision frameworks: a consensus framework from a European vaccine economics community B Ultsch, O Damm, P Beutels, J Bilcke, B Brüggenjürgen, A Gerber-Grote, ... Pharmacoeconomics 34, 227-244, 2016 | 125 | 2016 |
| Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany B Ultsch, I Köster, T Reinhold, A Siedler, G Krause, A Icks, I Schubert, ... The European Journal of Health Economics 14, 1015-1026, 2013 | 96 | 2013 |
| A systematic review of the health economic consequences of quadrivalent influenza vaccination PT de Boer, BM van Maanen, O Damm, B Ultsch, FCK Dolk, P Crépey, ... Expert review of pharmacoeconomics & outcomes research 17 (3), 249-265, 2017 | 66 | 2017 |
| Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries O Damm, B Ultsch, J Horn, RT Mikolajczyk, W Greiner, O Wichmann BMC Public Health 15, 1-19, 2015 | 54 | 2015 |
| Health economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in Germany B Ultsch, F Weidemann, T Reinhold, A Siedler, G Krause, O Wichmann BMC health services research 13, 1-18, 2013 | 53 | 2013 |
| Epidemiological impact and cost-effectiveness of universal vaccination with Bexsero® to reduce meningococcal group B disease in Germany H Christensen, T Irving, J Koch, CL Trotter, B Ultsch, F Weidemann, ... Vaccine 34 (29), 3412-3419, 2016 | 52 | 2016 |
| Cost-effectiveness of human papillomavirus vaccination in Germany O Damm, J Horn, RT Mikolajczyk, MEE Kretzschmar, AM Kaufmann, ... Cost Effectiveness and Resource Allocation 15, 1-19, 2017 | 49 | 2017 |
| Is the impact of childhood influenza vaccination less than expected: a transmission modelling study F Weidemann, C Remschmidt, S Buda, U Buchholz, B Ultsch, ... BMC infectious diseases 17, 1-14, 2017 | 41 | 2017 |
| Cost-effectiveness of childhood rotavirus vaccination in Germany P Aidelsburger, K Grabein, K Böhm, M Dietl, J Wasem, J Koch, B Ultsch, ... Vaccine, 2014 | 35 | 2014 |
| Epidemiology and cost of seasonal influenza in Germany-a claims data analysis S Scholz, O Damm, U Schneider, B Ultsch, O Wichmann, W Greiner BMC Public Health 19, 1-10, 2019 | 34 | 2019 |
| Current and future effects of varicella and herpes zoster vaccination in Germany–Insights from a mathematical model in a country with universal varicella vaccination J Horn, A Karch, O Damm, ME Kretzschmar, A Siedler, B Ultsch, ... Human vaccines & immunotherapeutics 12 (7), 1766-1776, 2016 | 34 | 2016 |
| Burden of herpes zoster in adult patients with underlying conditions: analysis of German claims data, 2007–2018 M Batram, J Witte, M Schwarz, J Hain, B Ultsch, M Steinmann, A Bhavsar, ... Dermatology and therapy 11 (3), 1009-1026, 2021 | 25 | 2021 |
| The cost-of-illness for invasive meningococcal disease caused by serogroup B Neisseria meningitidis (MenB) in Germany S Scholz, F Koerber, K Meszaros, RM Fassbender, B Ultsch, RR Welte, ... Vaccine 37 (12), 1692-1701, 2019 | 25 | 2019 |
| Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany - a mathematical modelling study Horn J, Damm O, Greiner W, Hengel H, Kretzschmar ME, Siedler A, Ultsch B ... BMC Med 16 (1), 3, 2018 | 24* | 2018 |
| Background paper to the decision not to recommend a standard vaccination with the live attenuated herpes zoster vaccine for the elderly in Germany: Statement of the German … German Standing Committee on Vaccination (STIKO) at the Robert Koch ... Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz 60 (10), 1162-1179, 2017 | 19 | 2017 |
| Effectiveness, population-level effects, and heath economics of measles and rubella vaccination O Wichmann, B Ultsch Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz 56, 1260-1269, 2013 | 18* | 2013 |
| Standardisierte Kostenberechnungen im deutschen Gesundheitswesen: Bericht der Arbeitsgruppe „Standardkosten “des Ausschusses „ökonomische Evaluation “der dggö S Scholz, J Biermann-Stallwitz, C Brettschneider, O Damm, A Freytag, ... Gesundheitsökonomie & Qualitätsmanagement 25 (01), 52-59, 2020 | 17 | 2020 |
Wolfgang GreinerProfessor für Gesundheitsökonomie und Gesundheitsmanagement, Universität Bielefeld在 uni-bielefeld.de 的电子邮件经过验证
